Novel Genetic Variants of HLA Gene Associated with Thai Behcet’s Disease (BD) Patients Using Next Generation Sequencing Technology
Author:
Sornsamdang Gaidganok1, Shobana John1, Chanprapaph Kumutnart2, Chantratita Wasun3, Chotewutmontri Sasithorn4, Limtong Preeyachat2, O-charoen Pichaya5, Sukasem Chonlaphat1
Affiliation:
1. Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 2. Division of Dermatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 3. Center for Medical Genomics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 4. Faculty of Medicine and Public Health, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy Bangkokthai 5. Division of Allergy, Immunology, and Rheumatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Abstract
Abstract
Behcet’s disease (BD) is a recurring inflammatory condition that mostly affects the eyes, mouth, and genitals, with organ involvement in the worst-case scenario. Along with environmental and other patient-related factors, genetic polymorphisms play a huge role in BD. This study aimed to investigate the susceptible genetic variants of HLA gene in 56 Thai BD patients and 192 healthy controls. HLA Genotyping was performed by next-generation sequencing (NGS) using a PacBio kit. The association was calculated by the multivariate logistic regression analysis. We found that the following alleles were found to be associated with BD: HLA-A*26:01:01 (OR=6.02, 95% CI=1.45-22.37, p=0.031), HLA-B*39:01:01 (OR=12.59, 95% CI=1.82-78.50, p=0.005), HLA-B*51:01:01 (OR=3.36, 95% CI=1.18-9.54, p=0.023), HLA-DQB1*05:03:01 (OR=9.35,95%CI=3.72-23.39, p=0.0001), and HLA-DRB1*14:54:01 (OR=32.48, 95% CI=18.11-60.78, p=0.001). When the association analysis was performed for a specific BD phenotype (ocular), HLA-DRB1*14:54:01 (OR=11.67, 95% CI=2.86-47.57, p = 0.001), HLA-B* 51:01:01 (OR=5.47, 95% CI=0.99-90.12, p = 0.05), and HLA-B* 51:01:02 (OR=5.33, 95% CI=1.23-23.06, p = 0.025) alleles had the association with ocular involvement in BD, and the HLA DRB1*14:54:01 (OR=3.35, 95% CI=1-11.99, p = 0.04) allele was found to be linked to vascular involvement in BD patients. In conclusion, for the first time in the Thai population, our study discovered susceptible novel alleles in BD patients such as HLA-A*26:01:01, HLA-B*39:01:01, HLA-B*51:01:01, HLA-DRB1*14:54:01, and HLA-DQB1*05:03:01. This highlights the necessity of genetic testing of the disease's risk alleles to diagnose BD. Despite these alleles have a lower positive predictive value, nearly all the observed risk alleles have significant negative predictive values.
Publisher
Research Square Platform LLC
Reference32 articles.
1. On relapsing, aphthous ulcers of the mouth, eye and genitalia caused by a virus. 1937;Behçet H;Clin Exp Rheumatol,2010 2. Behcet's disease;Davatchi F;Int J Rheum Dis,2014 3. Jennette JC. Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Clin Exp Nephrol. 2013;17(5):603-6. 4. Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives;Verity DH;Tissue Antigens,1999 5. Behçet syndrome: a contemporary view;Yazici H;Nature Reviews Rheumatology,2018
|
|